SEC Form 4 · accession 0001209191-18-034658
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
L Patrick Gage
Director
Period of report
May 30, 2018
Accepted (ET)
Jun 1, 2018 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $3.68 | May 30, 2018 | A | 12,500 | A | — | May 29, 2028 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1Vests in equal quarterly installments over a one-year period measured from the date of grant.